A Pilot Trial Using BR55 Ultrasound Contrast Agent in the Assessment of Prostate Cancer

Clinical trial NCT02142608 · COMPLETED

Trial details

NCT number: NCT02142608
Sponsor: Bracco Diagnostics, Inc
Status: COMPLETED
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Prostate Cancer

Start date: 2014-08-01
Primary completion: 2015-07-01
Enrollment: 19

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.